In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist

By Kato Y.   Kita Y.   Nishio M.   Hirasawa Y.   Ito K.   Yamanaka T.   Motoyama Y.   Seki J.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombin Receptor Antagonists for the Treatment of Atherothrombosis: Therapeutic Potential of Vorapaxar and E-5555

By Leonardi Sergio   Tricoci Pierluigi   Becker Richard C.  

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1771-1783

Adis International

Access to resources Recommend Favorite

Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 516-521

Bentham Science Publishers

Access to resources Recommend Favorite

Antagonism of GABA B receptors by morpholino-2-acetic acid derivatives Sch 54679 and Sch 51324 in rat brain

By Ong J.   Marino V.   Parker D.A.S.   Kerr D.I.B.   Blythin D.J.  

European Journal of Pharmacology, Vol. 369, Iss. 1, 1999-03 ,pp. : 33-37

Elsevier

Access to resources Recommend Favorite